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Plasma 5-hydroxyindoleacetic acid as an endogenous index of renal
plasma flow. 5-Hydroxyindoleacetic acid (5-HIAA), the major serotonin
metabolite, was measured in human plasma and urine using liquid
chromatography and electrochemical detection. The renal extraction of
5-HIAA was 78%, a value compatible with an almost complete extrac-
tion during a single passage of the blood through the kidney. In
addition, plasma levels of 5-HIAA measured in patients with a wide
range of renal function was inversely correlated (r = 0.85) with the
clearance of para-aminohippuric acid (PAH). The results indicate that
5-HIAA determinations can be used as an alternative procedure to the
PAH clearance method for the estimation of renal plasma flow in
clinical practice.
Levels of 5-hydroxyindoleacetic acid (5-HIAA), the major
serotonin metabolite, have been measured in the urine to
investigate the effects of drugs on serotonin (5-hydroxytrypta-
mine, 5-HT) metabolism [1—3] or to help in diagnosing patho-
logical states such as malignant carcinoid, phenylketonuria or
migraine [4—8]. Renal elimination of 5-HIAA, like that of
p-aminohippuric acid (PAH) is achieved by glomerular filtration
and active tubular secretion in the proximal tubule [9, 10].
Tubular secretion concerns the elimination of weak acids and is
due to an active transport mechanism which is inhibited by
probenecid [9, 10]. Interestingly, the excretion of 5-HIAA is not
altered by change of urinary pH or oral administration of fluid
[11, 12].
Since the 5-HIAA elimination is analogous to the PAH
system, it is expected that 5-HIAA clearance (or plasma level of
5-HIAA) parallels PAH clearance (or l/PAH clearance) classi-
cally used as an index of renal plasma flow [13, 14]. Indeed,
Despopoulos and Weissbach [9] demonstrated in a patient with
malignant carcinoid that the renal clearance of 5-HIAA was
much greater than the glomerular filtration rate. The recent
improvement in the electrochemical procedure used to detect
5-HIAA permitted the development of an assay of endogenous
5-HIAA in human plasma. In this study, we analyzed the renal
extraction coefficient of 5-HIAA, and compared the renal
clearance of 5-HIAA to the renal clearance of PAH to test
whether endogenous 5-HIAA could be used as an index of renal
plasma flow in humans.
5-HIAA determinations
Plasma and urine collections. A 2 ml sample of venous blood
was collected in heparinized tubes and centrifuged for five
minutes at 500 g. Plasma was stored at —18°C until the assay.
Table I shows the influence of the collection procedure on the
5-HIAA level. Platelet 5-HT stores do not affect plasma 5-
HIAA even after leaving the heparinized blood for two hours at
ambient temperature. However, when blood was collected
without heparin and clotted, the serum 5-HIAA was slightly
elevated when compared to plasma 5-HIAA, reflecting the
metabolism of 5-HT leaking from lysed platelets. On the day of
analysis, plasma was deproteinized by adding 10% HCIO4 4 N
and centrifuged for four minutes at 15000 g. Fifty d of the
supernatant was then injected into the chromatographic system.
Aliquots of urine (10 to 20 ml) were stored at —18°C until the
assay. On the day of the analysis, urine was diluted 10 times and
25 itl was injected into the chrornatographic system.
Chromatographic conditions. A coupling of liquid chroma-
tography with on-line amperornetric detection was used for
assaying plasma and urinary 5-HIAA. The general procedure
has been described elsewhere [15]. The mobile phase was a 3
vol!2 vol citric acid-monohydrogen phosphate buffer, pH 3.3,
containing 15% methanol. The glassy carbon working electrode
was set to a potential of + 500 mV against a silver-silver
chloride reference electrode. The eluting flow rate was 1.5 ml!
mm. In these conditions mean retention time for 5-HIAA was
10.2 minutes (Fig. 1). Fresh standard was injected the day of the
dosage (50 /11 of l0 mol/liter for plasma and 10 p1 of 10—6 molt
liter for urine). 5-HIAA was identified and quantified by com-
paring retention time and peak height to standards. The repro-
ducibility of the method was calculated from nine determina-
tions by the formula (1 — SD/rn) x 100%. Mean intra-assay
coefficients of reproducibility for plasmatic and urinary 5-HIAA
were 95.2% and 97.6%, respectively. Mean inter-assay coeffi-
cients of reproducibility for plasmatic and urinary 5-HIAA were
91.2% and 95.9%, respectively.
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Table 1. Effect of the collection procedure on plasma 5-HIAA level
Fig. 1. Chromatogram of a solution of
authentic 5-HIAA, (10—i mol/liter, 50 pi)
(right), and deproteinized plasma (50 pJ) from
a volunteer (middle) and a patient with a
renal failure (left).
A B C
Heparin 75 lU/mi 250 lU/mi 0 (serum)
Ascorbic acid l0— mol/liter 0 0
Centrifugation 1000 g for 10
mm
7000 g for 10 mm
after 2 hours
latency
7000 g for 10 mm
after 2 hours
latency
5-HIAA 3.73 0.39 3.87 0.41 4.5 0.32a
10 mol/liter
Mean SF.M, N = 6
P < 0.05 for comparison with A, paired t-test
Venous sampling for extraction ratio determinations
Multiple venous blood samplings were performed in seven
hypertensive patients (2 females and 5 males, 12 to 64 years and
34.9 6.1 years, respectively, mean SEM) in order to
compare renin secretion of both kidneys. Creatinine clearance
was in the normal range in all cases. We used inferior venous
cava (IVC) blood (sampled below renal veins) as an equivalent
of peripheral (arterial) blood. We also obtained an arterial
sample in one case and arterial and IVC 5-HIAA concentrations
were equal. Blood sample from the renal vein (RV) of the
control side was used to estimate 5-HIAA renal extraction ratio
using the formula:
Extraction ratio = [(IVC — RV)/IVC] x 100%.
Clearance determinations
Four healthy volunteers and 23 patients (20 males and 7
females, l9to 83 years and 36.7 3.1 years, respectively, mean
SEM) were investigated. We included patients with varying
Fig. 2. Direct correlation between P5-HIAA and CrAg (N = 27).
degrees of renal failure seconoary to nypertension, nephroli-
thiasis, chronic glomerulonephritis or interstitial nephropathy.
All subjects were studied during the morning after fasting
overnight. None was receiving any drug for the day of investi-
gation. Each subject drank 500 ml water 30 minutes before
emptying the bladder, and water loading was maintained by an
intake of 300 ml of water every 30 minutes for the duration of
the study. A bolus of 10 ml of a saline solution containing inulin
(40 mg x kg body wt; mutest®, Laevosan Gmbh, Linz, Austria)
and PAH (8 mg x kg body wt; Nephrotest®, Ba Gmbh Lich,
FRG) was injected intravenously, followed by an infusion of a
saline solution containing inulin (100 mg x estimated ml/min
GFR per liter) and PAH (50 mg x estimated GFR per liter) at a
constant rate of 2 mI/mm for 150 minutes. Estimated GFR was
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calculated according to Cockroft's formula. With this protocol,
plasma concentration plateaus of 200 mg/liter for inulin and 10
mg/liter for PAH were obtained. After 90 minutes of equilibra-
tion, two consecutive clearance periods of 30 minutes each
were evaluated. Urine was collected every 30 minutes by
voluntary voiding, Blood specimen was drawn at the beginning
and the end of each collection period. A specimen of the
infusion solution was collected for assaying inulin and PAH.
Plasma and infusion solution concentrations of inulin and PAH
were determined by a colorimetric reaction using an autoana-
lyzer Technicon I (Technicon Instruments, Tarrytown, New
York, USA). 5-HIAA and creatinine were measured on the first
sample of each period. Plasma and urine creatinine were
assayed by the Jaffe's kinetic method with an Astra 8 Beckman
Analyzer (Beckman Instruments, Fullerton, California, USA).
Clearances were calculated using the standard clearance for-
mula: C = UV/P, where V is the urine flow, U the urine
concentration of the substance and P its plasma level. The mean
of the two determinations were used for comparisons.
Results
The 5-HIAA extraction ratio calculated from caval and renal
venous samplings was 78.4 2.5% (mean SEM, 72 to 88%,
N = 7). This very high extraction ratio was also illustrated by
the CSHIAA/CIfl ratio calculated for each patient included in the
clearance determination study. This ratio was 6.30 0.66
(mean SEM, N = 27) calculated in the same patients. The
most striking result of this study is illustrated in Figures 2 and
3. The correlation coefficient of the inverse relationship be-
tween 5HIAA and CPAH was very high (r = 0.85, P < 0.001,
N = 27). 5HIAA was stable during the investigation period
(difference between the first and the last 5-HIAA determination:
0.15 0.11 10-8 mol/liter, NS, N = 27). The direct correlation
between C5HIAA and CPAH shown in Figure 4 was also highly
significant (r = 0.76, P < 0.001, N = 27) with a slope of 1.15
(CSHJAA = 1.15 CPAH — 16). 5-HIAA was inversely correlated
with CSHIAA (CSHIAA = (l234/P51AA) — 3.7, r = 0.76, P <
0.001, N = 27). This study also confirmed the very close
CPAH, mi/mm
Fig. 4. Direct correlation between C5HIAA and CPAH (C5HJAA = 1.15
CPAH — 16, N = 27, r = 0.76, P < 0.00/).
relationship between Cr and C1 (Car = 0.97 C1 + 13, r =
0.93, P < 0.001, N = 27).
Discussion
The test using PAH clearance provides an accurate index of
renal plasma flow because this compound is almost completely
extracted during a single passage of the blood through the
kidney. However the extraction ratio in humans varies from
about 0.7 to 0.9 at plasma concentrations well below the
transport maximum [13]. The main reason for the incomplete
extraction of PAH is a failure of part of the blood supply to the
medulla to perfuse pars recta segments of proximal tubules
(sites of PAH secretion) [13]. This anatomical feature is appli-
cable to the other compounds eliminated via the same mecha-
nisms and implies that the extraction ratio of such compounds
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fall within the range of the PAH extraction ratio. The presently
observed 5-HIAA extraction ratio of 0.78 is therefore a satis-
factory result in agreement with the working hypothesis that
this metabolite is almost completely extracted during a single
passage of the blood through the kidney. An incomplete cortical
extraction, evidenced with PAH [161, could also occur for
5-HIAA and account for its reduced extraction ratio. This
similarity, together with the complexity of the PAH clearance
determination which restricts the use of the method to clinical
research led us to carefully compare plasma levels and renal
clearance of 5-HIAA to the reference PAH method. The recent
development of LCEC helped us to assay plasma levels of
5-HIAA, which has the considerable advantage over the PAH
of being an endogenous compound and therefore obviating the
need of an infusion.
The glomerular filtration of the 27 patients estimated from the
inulin clearance ranged from 14 to 152 mi/mm. The PAH
clearance used as the reference method for renal plasma flow
was largely in excess of inulin clearance, ranging from 134 to
788 ml/min, with a mean CPAH/CIfl of 5.63 (1/filtration fraction).
The most striking result of this study was the strong inverse
correlation (r = 0.85, P <0.001) between 5-H1AA and CPAH.
This relation indicates that plasma 5-HIAA reflects renal
plasma flow estimated from CPAH. The formula of a hyperbola
and the results, as may be seen in Figures 2 and 3, agree with
the theoretical assumption. Such an hyperbolic (inverse) rela-
tionship has been repeatedly observed between endogenous
creatinine level and glomerular filtration rate [171. Brod [17]
pointed out that deviations from this relationship may occur if
the investigation is not carried out in a metabolic steady state.
Plasma 5-HIAA, like plasma creatinine, depends of both its
renal elimination and total body production. This latter factor
being not controlled, one should therefore assume that 5-HIAA
formation was similar in all the tested patients, whatever their
renal status. Actually the main influence over 5-HIAA produc-
tion is the dietary intake of serotonin (converted to 5-HIAA) or
the intake of ethanol, reducing the 5-HT metabolic conversion
to 5-HIAA [6]. Since the blood was drawn in the morning while
patients were fasting, these dietary factors were minimized and
only the metabolism of endogenously released 5-HT was re-
sponsible for 5-HIAA production. This probably reduced the
deviation from the inverse relationship between 5HIAA and
CPAH which was therefore mainly dependent upon the renal
status. The upper plasma 5-HIAA level which was observed
with a renal plasma flow within normal limits was 4.l0_8 M.
When the 5-HIAA level exceeded 4.108 M practically all the
subjects had reduced rates of renal plasma flow. The hyperbolic
relationship makes uneasy the estimation of high plasma flows,
but within low renal plasma flow ranges plasma 5-HIAA levels
are markedly affected (Fig. 2).
5-HIAA clearance largely exceeded inulin clearance, with a
mean C5HJAA/CIfl of 6.30, confirming that 5-HIAA is actively
secreted by the kidney. CSHIAA was correlated with CPAH (r
0.76, P < 0.001) but the correlation was not as strong as the
inverse correlation between 5.HIAA and CPAH (r =0.85). The
reason for this discrepancy between the quality of the two
correlations could depend upon several factors, such as the
analytical procedure used for urinary 5-HIAA and/or an intra-
renal 5-HIAA metabolism.
In conclusion, the present study confirms that 5-HIAA is
almost completely extracted during a single passage of the
blood through the kidney. Being an endogenous substance
easily assayed in plasma by using liquid chromatography and
electrochemical detection, we recommend its use in clinical
practice for a quick orientation on renal plasma flow.
Reprint requests to J.L. Elghozi, Department of Pharmacology,
INSERM U7, Facu!té de Medecine Necker-Enfants Malades, 156 rue
de Vaugirard, 75015 Paris, France.
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